1-20 of 24
Keywords: BPH
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas
European Urology (1997) 32 (Suppl. 1): 9–14.
Published Online: 19 February 2019
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Bladder neck obstruction Ageing BPH Microscopy Collagen Autonomic nerves European Urology EurUrol 1997;32(suppl 1):9-14 1617479 J.A. Gosling The Chinese University...
Journal Articles
Subject Area:
Further Areas
European Urology (1997) 32 (Suppl. 1): 3–8.
Published Online: 19 February 2019
... of irritative and obstructive symptoms of BPH. This paper illustrates the anatomical changes within the pelvic region that can develop as a consequence of prostatic enlargement. The anatomical position of the prostate is such that its enlargement inevitably affects neighbouring organs. Enlargement of the median...
Journal Articles
Subject Area:
Further Areas
European Urology (1997) 32 (Suppl. 1): 28–31.
Published Online: 19 February 2019
...F. Desgrandchamps Changing demography and expectations about maintaining quality of life mean that an increasing number of men will require treatment for benign prostatic hyperplasia (BPH). Many growth factors have a role in the development of BPH. Consequently growth factor antagonists offer...
Journal Articles
Subject Area:
Further Areas
European Urology (1997) 32 (Suppl. 1): 32–39.
Published Online: 19 February 2019
...R. Buttyan; M.-W. Chen; R.M. Levin In humans, chronic bladder outlet obstruction resulting from benign prostatic hypertrophy (BPH) can induce severe and irreversible upper urinary tract changes, especially in the bladder. BPH can be mimicked in rabbits by artificially creating a partial obstruction...
Journal Articles
Subject Area:
Further Areas
European Urology (1997) 32 (Suppl. 1): 22–27.
Published Online: 19 February 2019
...R.K. Lawson Benign prostatic hyperplasia (BPH) is a common condition among older men. Although surgery is the most effective treatment for patients with severe symptoms of bladder outlet obstruction, many patients with less severe symptoms will benefit from pharmacological intervention. Traditional...
Journal Articles
Subject Area:
Further Areas
European Urology (1997) 32 (Suppl. 1): 15–21.
Published Online: 19 February 2019
...R.M. Levin; S.S. Levin; Y. Zhao; R. Buttyan Bladder dysfunction secondary to benign prostatic hyperplasia (BPH) is a major affliction associated with ageing. As the disease slowly progresses, the bladder changes from a state of compensation to decompensation, in which there are severe, irreversible...
Journal Articles
Subject Area:
Further Areas
European Urology (1993) 23 (2): 302–306.
Published Online: 11 August 2017
...M. Vandenbossche; A. Peltier; C.C. Schulman In 2 years, 191 patients with symptomatic benign prostatic hypertrophy(BPH) were treated by transurethral radiofrequency heating of the prostate at various temperatures (44.5 and 47-48 °C) in one session. At 44.5 °C, 60% of the patients were subjectively...
Journal Articles
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 439–442.
Published Online: 16 April 2012
... to values obtained from an age-matched group of patients with benign prostatic hyperplasia (BPH). The data demonstrated significant differences in the enzyme activity for both tissue types with the mean values of the CaP group being markedly depleted when compared to the hyperplastic specimens (p < 0.005...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 39 (Suppl. 6): 19–26.
Published Online: 17 November 2004
...Ph.E.V. van Kerrebroeck Objectives: To assess the long-term efficacy and safety of alfuzosin 10 mg OD in patients with symptomatic BPH. Methods: Patients (>50 years) were randomised to alfuzosin 10 mg OD, alfuzosin 2.5. mg t.i.d. or placebo for 3 months. Open-label alfuzosin 10 mg OD...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 39 (Suppl. 6): 13–18.
Published Online: 17 November 2004
...R. Hartung Acute urinary retention (AUR) is a common complication of benign prostatic hyperplasia (BPH) and the incidence varies widely from 0.4 to 25% per year in men seen in urology practices. It has been estimated that AUR is the indication for surgery in around 25–30% of patients undergoing...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 40 (Suppl. 4): 5–11.
Published Online: 19 December 2001
...David Price This paper reviews the role of α 1 -adrenoceptors (ARs) in the aetiology of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). α 1 -ARs have been demonstrated to be present and functionally active in the human prostate where the α 1A -AR subtype...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 40 (Suppl. 4): 21–30.
Published Online: 19 December 2001
...Mark J. Speakman Management of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) requires careful thought so that the most appropriate treatment can be targeted to each individual patient. Initial choices in the management of LUTS/BPH include watchful waiting...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 40 (Suppl. 4): 12–20.
Published Online: 19 December 2001
...Roberto M. Scarpa Patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) complain about symptoms such as weak stream, dribbling, intermittency, frequency, nocturia and urgency. To effectively manage these symptoms, it is important to better understand...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 40 (Suppl. 3): 8–12.
Published Online: 19 December 2001
...Claude C. Schulman Acute urinary retention (AUR) is an important complication of benign prostatic hyperplasia (BPH) and can affect 0.4–25% of men seen in urological practice each year. AUR is also one of the main indications for surgery, being the presenting features of 25–30% of transurethral...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 40 (Suppl. 3): 13–18.
Published Online: 19 December 2001
...Michael P. O’Leary Benign prostatic hyperplasia (BPH) can impact significantly on a patient’s quality of life (QOL), including sexual functioning. With increased life expectancy, this aspect of the disease is becoming increasingly important. Symptom severity can be measured using a number...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 40 (Suppl. 3): 2–7.
Published Online: 19 December 2001
...François Desgrandchamps In making treatment decisions for patients with benign prostatic hyperplasia (BPH), physicians have to rely on the efficacy data published in the literature and adapt this to individual patient’s needs. Criticism can be made, however, of the randomised clinical trials (RCTs...
Journal Articles
Subject Area:
Further Areas
European Urology (2001) 39 (Suppl. 3): 6–12.
Published Online: 15 March 2001
... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. LUTS BPO BPH Evidence-based medicine...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Further Areas
European Urology (2000) 37 (4): 381–385.
Published Online: 17 March 2000
...Roberto Mario Scarpa; Antonello De Lisa; Daniele Porru; Enzo Usai Objective: We intended to ascertain the true role played by large–size prostatic glands with BPH in impeding ureteroscopy; since no such impediment was experienced by the authors, we then listed the most frequent obstacles...